ERBA Diagnostics Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2010
2011
2012
2013
2014
Sales/Revenue
17,031.70
16,759.80
19,349.00
28,255.30
26,391.60
Cost of Goods Sold (COGS) incl. D&A
8,212.70
8,158.50
10,257.40
14,442.80
13,778.10
Gross Income
8,819.10
8,601.30
9,091.60
13,812.50
12,613.50
SG&A Expense
12,992.00
11,829.60
10,294.80
12,775.80
11,740.50
EBIT
4,172.90
3,228.30
1,203.20
1,036.70
873.00
Unusual Expense
-
327.00
211.10
211.00
-
Non Operating Income/Expense
65.50
12.10
22.80
91.20
268.30
Interest Expense
-
22.00
39.80
122.00
38.40
Pretax Income
4,103.40
3,589.30
1,431.30
794.90
566.20
Income Tax
111.30
292.00
122.00
119.10
116.60
Consolidated Net Income
4,214.70
3,297.30
1,553.40
675.80
449.60
Net Income
4,214.70
3,297.30
1,553.40
675.80
449.60
Net Income After Extraordinaries
4,214.70
3,297.30
1,553.40
675.80
449.60
Net Income Available to Common
4,214.70
3,297.30
1,553.40
675.80
449.60
EPS (Basic)
0.15
0.11
0.04
0.01
0.01
Basic Shares Outstanding
27,649.90
31,058.50
36,947.30
43,658.20
43,883.00
EPS (Diluted)
0.15
0.11
0.04
0.01
0.01
Diluted Shares Outstanding
27,649.90
31,058.50
36,947.30
48,542.70
54,842.70
EBITDA
3,309.30
2,491.90
477.00
2,033.30
1,936.40
Non-Operating Interest Income
4.10
-
-
-
-

About ERBA Diagnostics

View Profile
Address
14100 NW 57th Court
Miami Lakes Florida 33014
United States
Employees -
Website http://erbadiagnostics.com
Updated 07/08/2019
ERBA Diagnostics, Inc. is engaged in manufacturing and marketing of proprietary diagnostic reagents, test kits and instrumentation in the areas of autoimmune, chemistry, hematology, diabetes, and infectious diseases. It operates through the Domestic Region and European Region segments. The Domestic Region segment contains its subsidiaries located in the United States and in Latin American and corporate operations.